What Happened: FDA Shortage Resolution Timeline According to FDA announcements and independent legal reporting: October 2024: FDA determined the tirzepatide injection shortage (Mounjaro and Zepbound) was resolved, indicating the manufacturer could meet national demand
Instead of providing immediate volume, it stimulates collagen production in the skin over time
Including myHMB makes sense as a countermeasure, though whether the dose in this formula suffices for meaningful muscle preservation remains unknown
Food groups and risk of coronary heart disease, stroke and heart failure: a systematic review and dose-response meta-analysis of prospective studies
For practical patient counseling guidance: Share Nutrition Tips With Patients on a GLP-1 Agonist Related Clinical Considerations Medication management strategies may differ in older adults
Shah PJR, Green NA, Adib RS, et al